Stay updated on Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial

Sign up to get notified when there's something new on the Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The record now presents details for the completed Phase 3 study of valoctocogene roxaparvovec for hemophilia A, including its eligibility criteria, study design, outcomes, location, and study documents.
    Difference
    46%
    Check dated 2026-11-08T05:00:44.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T02:14:32.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site banner announces an NIH website transition and says that some NIH content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).
    Difference
    1%
    Check dated 2026-10-25T02:06:38.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T01:48:52.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The site footer now shows revision v3.7.1 instead of v3.7.0; the study page still displays a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T02:31:39.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error instead of the expected study details and navigation. This indicates an access issue rather than a substantive update to the study information.
    Difference
    18%
    Check dated 2026-09-20T01:29:55.000Z thumbnail image

Stay in the know with updates to Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial page.